Travere Therapeutics Inc (TVTX) financials · rev $490.7M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Travere Therapeutics Inc (TVTX) rev $490.7M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $490.7M | $233.2M |
| Cost of Revenue | $10.3M | $7.74M |
| Gross Profit | $480.4M | $225.4M |
| Operating Income | -$62.8M | -$323.8M |
| Net Income | -$25.5M | -$321.5M |
| EPS (Diluted) | -$0.29 | -$4.08 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $605.2M | $594.1M |
| Current Assets | $437.6M | $416.7M |
| Cash & Equivalents | $93.0M | $58.5M |
| Inventory | $36.2M | $6.20M |
| PP&E | $4.02M | $5.34M |
| Total Liabilities | $490.4M | $535.0M |
| Current Liabilities | $159.9M | $200.8M |
| Shareholders' Equity | $114.8M | $59.1M |
| Retained Earnings | -$1.47B | -$1.45B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $37.8M | -$237.5M |
| Investing Cash Flow | $27.9M | $99.3M |
| Financing Cash Flow | -$33.5M | $139.4M |
| Net Change in Cash | $34.5M | $359.0K |
FAQ
What is TVTX P/E and revenue?
Travere Therapeutics Inc (TVTX) rev $490.7M.
What is TVTX revenue?
Travere Therapeutics Inc last cached revenue is $490.7M (FY2025).
Is TVTX profitable?
Travere Therapeutics Inc last cached net income is -$25.5M (FY2025).
What are TVTX total assets?
Travere Therapeutics Inc last cached total assets are $605.2M (FY2025).
What is TVTX free cash flow?
No cached cash-flow row for TVTX yet.
Not investment advice. Cached statements, not a live tape.